Latest New Zealand News

Centrex Limited corrects its corporate presentation title to January 2025 and details progress on its Ardmore Phosphate Project Stage 1.5 Expansion, supported by a $10.4 million Entitlement Offer aimed at boosting production capacity and financial stability.

Hazer Group has successfully completed its Commercial Demonstration Plant program ahead of schedule, validating its methane pyrolysis technology and securing significant funding to accelerate commercialisation in 2025.

Rio Tinto's Q4 2024 production results reflect steady operational performance with record bauxite output and significant progress on key growth projects like Oyu Tolgoi and Rincon lithium expansion.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Fonterra Shareholders' Fund has secured conditional approval to delist from the ASX, aiming to consolidate its trading on the NZX by late February 2025. This move is expected to streamline operations and reduce costs for unitholders.

Centrex Limited has initiated a $10.4 million entitlement offer to fund essential plant upgrades and strengthen working capital, following a strategic logistics debt restructuring. The raise is pivotal for advancing the Ardmore phosphate project and maintaining financial viability.

Foresta Group Holdings secures a significant regulatory boost as its Kawerau renewable energy project is included in New Zealand’s Fast-Track Approvals Act 2024, expediting the path to construction and operation.

New Zealand Coastal Seafoods has detailed the terms of its recent $270,000 convertible note subscription following an ASX inquiry, confirming lender identities, conversion pricing, and compliance with disclosure rules.